Accueil/Actions/ENTX

ENTX

USD

Entera Bio Ltd. Ordinary Shares

$2.100-0.090 (-4.110%)

Prix en Temps Réel

Healthcare

Biotechnologie

Israël

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$2.190

Haut

$2.280

Bas

$2.040

Volume

0.01M

Fondamentaux de l'Entreprise

Capitalisation Boursière

95.4M

Industrie

Biotechnologie

Pays

Israel

Statistiques de Trading

Volume Moyen

0.04M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.41Actuel $2.100Haut $2.79

Actualités Connexes

15 avr. 2025 · 12:30

GlobeNewswire

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

JERUSALEM, April 15, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, announced highlights from Dr. Rachel B Wagman's oral

Entera Bio's EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO

28 mars 2025 · 20:05

GlobeNewswire

Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates

JERUSALEM, March 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ:ENTX), a leader in the development of oral peptides and proteins replacement therapies, today reported financial results and key business